80
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Central Composite Designed Solid Dispersion for Dissolution Enhancement of Fluvastatin Sodium By Kneading Technique

ORCID Icon, ORCID Icon &
Pages 313-328 | Received 11 Mar 2020, Accepted 15 May 2020, Published online: 03 Jun 2020

References

  • Larocque G , ArnoldAA , ChartrandE , MougetY , MarcotteI. Effect of sodium bicarbonate as a pharmaceutical formulation excipient on the interaction of fluvastatin with membrane phospholipids. Eur. Biophys. J.39(12), 1637–1647 (2010).
  • Ozkan SA , UsluB. Electrochemical study of fluvastatin sodium – analytical application to pharmaceutical dosage forms, human serum, and simulated gastric juice. Anal. Bioanal. Chem.372(4), 582–586 (2002).
  • Karavas E , KoutrisE , PapadopoulosAGet al. Application of density functional theory in combination with FTIR and DSC to characterise polymer drug interactions for the preparation of sustained release formulations between fluvastatin and carrageenans. Int. J. Pharm.466(1–2), 211–222 (2014).
  • Plosker GL , WagstaffAJ. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia. Drugs51(3), 433–459 (1996).
  • Tank CJ , KapseGK , SarvaiyaJI. Transdermal drug delivery of fluvastatin sodium: effect of permeation enhancers and pressure sensitive adhesive. J. Pharm. Res.6(5), 573–578 (2013).
  • Li J , YangM , XuW. Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin. Drug Des. Dev. Ther.12, 3491–3499 (2018).
  • Kamboj A , KaurM , BalaI , JainUK. Formulation and evaluation of fast dissolving oral films of fluvastatin sodium by using taste masking techniques. J. Biomed. Pharm. Res.5(3), 62–70 (2016).
  • Papageorgiou GZ , PapadimitriouS , KaravasE , GeorgarakisE , DocoslisA , BikiarisD. Improvement in chemical and physical stability of fluvastatin drug through hydrogen bonding interactions with different polymer matrices. Curr. Drug Deliv.6(1), 101–112 (2009).
  • Ghareeb MM , AbdulrasoolAA , HusseinAA , NoordinMI. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS Pharm. Sci. Tech.10(4), 1206–1215 (2009).
  • Modi A , TayadeP. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS Pharm. Sci. Tech.7(3), E87–E92 (2006).
  • Yadav PS , KumarV , SinghUP , BhatHR , MazumderB. Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol. Saudi. Pharm. J.21(1), 77–84 (2013).
  • Dos Santos KM , BarbosaRM , VargasFGAet al. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method. Drug Dev. Ind. Pharm.44(5), 750–756 (2018).
  • Febriyenti F , RahmiS , HalimA. Study of gliclazide solid dispersion systems using PVP K-30 and PEG 6000 by solvent method. J. Pharm. Bioall. Sci.11(3), 262–267 (2019).
  • Febriyenti F , SuraiyaR , AuzalH. Study of gliclazide solid dispersion systems using PVP K-30 and PEG 6000 by solvent method. J. Pharm. Bioallied Sci.11(3), 262–267 (2019).
  • Liandong HU , DeliangGU , QiaofengHU , YanjingShi , GaoNa. Investigation of solid dispersion of atorvastatin calcium in polyethylene glycol 6000 and polyvinylpyrrolidone. Trop. J. Pharm. Res.13(6), 835–842 (2014).
  • Zhai X , LiC , BinhLenon G , XueCC , LiW. Preparation and characterization of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones. Asian. J. Pharm. Sci.12(1), 85–97 (2017).
  • Biswal S , SahooJ , MurthyPN. Characterization of gliclazide-PEG 8000 solid dispersions. Trop. J. Pharm. Res.8, 417–424 (2009).
  • Koh PT , ChuahJN , TalekarM , GorajanaA , GargS. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems. Indian J. Pharm. Sci.75(3), 291–301 (2013).
  • Sahoo J , BiswalS , MurthyPN , GiradkarRP , AvariJG. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech.9(2), 563–570 (2008).
  • Patil MP , GaikwadNJ. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions. Acta. Pharm.59, 57–65 (2009).
  • Sharma N , SinghS. Central composite designed ezetimibe solid dispersion for dissolution enhancement: synthesis and in vitro evaluation. Ther. Deliv.10(10), 643–658 (2019).
  • Lewis GA , MathieuD , Phan-Tan-LuuR. Pharmaceutical Experimental Design.1st Edition,Marcel Dekker Inc, NY, USA (1999).
  • Myers WR . Response surface methodology In: ChowSC. Encyclopedia of Biopharmaceutical Statistics.Marcel Dekker Inc,NY, USA, 858–869 (2003).
  • Mahajan A , SurtiN , KoladiyaP. Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 32 factorial design. Drug Dev. Ind. Pharm.44(3), 463–471 (2018).
  • Higuchi T , ConnorsKK. Phase-solubility techniques. Adv. Anal. Chem. Instrum.4, 117–123 (1965).
  • McKenna A , McCaffertyDF. Effect of particle size on the compaction mechanism and tensile strength of tablets. J. Pharm. Pharmacol.34(6), 347–351 (1982).
  • Vaingankar P , AminP. Continuous melt granulation to develop high drug loaded sustained release tablet of Metformin HCl. Asian J. Pharm. Sci.12(1), 37–50 (2017).
  • El-Helw ARM , FahmyUA. Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers. Int. J. Nanomed.10, 5797–5804 (2015).
  • Costa P , SousaLobo JM. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci.13(2), 123–133 (2001).
  • Maswadeh HM , SemreenMH , AbdulhalimAA. In-vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices. Acta Pol. Pharm.63(1), 63–67 (2006).
  • Peppas NA , SahlinJJ. A simple equation for the description of solute release. iii. coupling of diffusion and relaxation. Int. J. Pharm.57(2), 169–172 (1989).
  • Maulvi FA , ThakkarVT , SoniTG , GandhiTR. Optimization of aceclofenac solid dispersion using box-behnken design: in-vitro and in-vivo evaluation. Curr. Drug Deliv.11(3), 380–391 (2014).
  • Pawar J , TayadeA , GangurdeA , MoravkarK , AminP. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: a QbD approach. Eur. J. Pharm. Sci.88, 37–49 (2016).
  • Singh J , GargR , GuptaGD. Enhancement of solubility of lamotrigine by solid dispersion and development of orally disintegrating tablets using 32 full factorial design. J. Pharm.1–8 (2015).
  • Sharma A , JainCP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res. Pharm. Sci.5(1), 49–56 (2010).
  • Weuts I , KempenD , VerreckGet al. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG 6000 prepared by spray drying. Eur. J. Pharm Biopharm.59(1), 119–126 (2005).
  • Pawar J , TayadeA , GangurdeA , MoravkarK , AminP. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: a QbD approach. Eur. J. Pharm. Sci.88, 37–49 (2016).
  • Parmar KR , ShahSR , ShethNR. Preparation, characterization, and in vitro evaluation of ezetimibe binary solid dispersions with poloxamer 407 and PVP K30. J. Pharm. Innov.6(2), 107–114 (2011).
  • Gohel MC , PatelLD. Processing of nimesulide-PEG 400-PG-PVP solid dispersions: preparation, characterization, and in vitro dissolution. Drug Dev. Ind. Pharm.29(3), 299–310 (2003).
  • Brian JK , SeyedMT , GordonLA , GregoryEA. In vivo predictive dissolution: comparing the effect of bicarbonate and phosphate buffer on the dissolution of weak acids and weak bases. J. Pharm. Sci.104(9), 2894–2904 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.